257 related articles for article (PubMed ID: 16598333)
1. Leiomyosarcoma of the bladder in a 16-year-old girl with a history of cyclophosphamide therapy for bilateral retinoblastoma during infancy.
Al-Zahrani AA; Kamal BA; Eldarawani HM; Hashim TM
Saudi Med J; 2006 Apr; 27(4):531-3. PubMed ID: 16598333
[TBL] [Abstract][Full Text] [Related]
2. A second leiomyosarcoma in the urinary bladder of a child with a history of retinoblastoma 12 years following partial cystectomy.
Brucker B; Ernst L; Meadows A; Zderic S
Pediatr Blood Cancer; 2006 Jun; 46(7):811-4. PubMed ID: 16470582
[TBL] [Abstract][Full Text] [Related]
3. Leiomyosarcoma of the bladder fourteen years after cyclophosphamide therapy for retinoblastoma.
Motta L; Porcaro AB; Ficarra V; D'Amico A; Piubello Q; Comunale L
Scand J Urol Nephrol; 2001 Jun; 35(3):248-9. PubMed ID: 11487082
[TBL] [Abstract][Full Text] [Related]
4. Leiomyosarcoma of urinary bladder following cyclophosphamide therapy: report of two cases.
Tanguay C; Harvey I; Houde M; Srigley JR; Têtu B
Mod Pathol; 2003 May; 16(5):512-4. PubMed ID: 12748258
[TBL] [Abstract][Full Text] [Related]
5. Leiomyosarcoma in urinary bladder after cyclophosphamide therapy for retinoblastoma and review of bladder sarcomas.
Parekh DJ; Jung C; O'Conner J; Dutta S; Smith ER
Urology; 2002 Jul; 60(1):164. PubMed ID: 12100953
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic review of enucleated eyes after intra-arterial chemotherapy with melphalan for advanced retinoblastoma.
Vajzovic LM; Murray TG; Aziz-Sultan MA; Schefler AC; Fernandes CE; Wolfe SC; Hess DJ; Dubovy SR
Arch Ophthalmol; 2010 Dec; 128(12):1619-23. PubMed ID: 21149791
[No Abstract] [Full Text] [Related]
7. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
Chantada GL; Dunkel IJ; Antoneli CB; de Dávila MT; Arias V; Beaverson K; Fandiño AC; Chojniak M; Abramson DH
Pediatr Blood Cancer; 2007 Sep; 49(3):256-60. PubMed ID: 17029248
[TBL] [Abstract][Full Text] [Related]
8. Orbital leiomyosarcoma after retinoblastoma.
Klippenstein KA; Wesley RE; Glick AD
Ophthalmic Surg Lasers; 1999; 30(7):579-83. PubMed ID: 10929985
[TBL] [Abstract][Full Text] [Related]
9. Leiomyosarcoma of the urinary bladder in a patient with bilateral retinoblastoma.
Minagawa T; Okaneya T; Kamigaito M; Nishizawa S; Ogawa T; Kawakami M; Nakayama T; Imamura T; Kato H; Nishizawa O
Int J Urol; 2008 Jun; 15(6):548-50. PubMed ID: 18489647
[TBL] [Abstract][Full Text] [Related]
10. Recurring multifocal leiomyosarcoma of the urinary bladder 22 years after therapy for bilateral (hereditary) retinoblastoma: a case report and review of the literature.
Svajdler M; Andrašina I; Ilenčíková D; Rychlý B; Piačková B
Cesk Patol; 2012 Jan; 48(1):44-8. PubMed ID: 22716012
[TBL] [Abstract][Full Text] [Related]
11. Chemoreduction in the management of retinoblastoma.
Shields JA; Shields CL; Meadows AT
Am J Ophthalmol; 2005 Sep; 140(3):505-6. PubMed ID: 16139001
[No Abstract] [Full Text] [Related]
12. Retinoblastoma in Infancy with Subsequent Bladder Leiomyosarcoma in Adulthood: Genomic Considerations.
Ohan H; Minassian G; Minassian H; Farooq T; Zdilla MJ
Urology; 2020 Jun; 140():38-40. PubMed ID: 32197986
[TBL] [Abstract][Full Text] [Related]
13. Management of porous polyethylene implant exposure in patients with retinoblastoma following enucleation.
Kim JH; Khwarg SI; Choung HK; Yu YS
Ophthalmic Surg Lasers Imaging; 2004; 35(6):446-52. PubMed ID: 15580966
[TBL] [Abstract][Full Text] [Related]
14. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy.
Shields CL; Shields JA
Curr Opin Ophthalmol; 2010 May; 21(3):203-12. PubMed ID: 20224400
[TBL] [Abstract][Full Text] [Related]
15. Bladder Leiomyosarcoma 25 Years after Treatment with Cyclophosphamide in Patient with History of Retinoblastoma.
Ramírez Sevilla C; Admella-Salvador C; Romero-Martin JA; Llopis-Manzanera J; Barranco-Sanz MA
Urol Int; 2018; 100(1):119-121. PubMed ID: 26675030
[TBL] [Abstract][Full Text] [Related]
16. Bladder carcinoma associated with cyclophosphamide therapy for ovarian cancer occurring with a latency of 20 years.
Volm T; Pfaff P; Gnann R; Kreienberg R
Gynecol Oncol; 2001 Jul; 82(1):197-9. PubMed ID: 11426986
[TBL] [Abstract][Full Text] [Related]
17. The success of primary chemotherapy for group D heritable retinoblastoma.
Cohen VM; Kingston J; Hungerford JL
Br J Ophthalmol; 2009 Jul; 93(7):887-90. PubMed ID: 18703556
[TBL] [Abstract][Full Text] [Related]
18. Pleomorphic adenoma of the lacrimal gland in an 18-year-old girl irradiated for bilateral retinoblastoma.
Hadjistilianou T; de Francesco S; Signori C; Menicacci F; Galluzzi P; Toti P
Orbit; 2006 Mar; 25(1):51-3. PubMed ID: 16527777
[TBL] [Abstract][Full Text] [Related]
19. A 30-month prospective study on the treatment of retinoblastoma in the Gabriel Toure Teaching Hospital, Bamako, Mali.
Boubacar T; Fatou S; Fousseyni T; Mariam S; Fatoumata DT; Toumani S; Abdoul-Aziz D; Marouf KM
Br J Ophthalmol; 2010 Apr; 94(4):467-9. PubMed ID: 19822911
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
